WEBULL
News
CING
6.90
-4.43%
-0.32
Weekly Report: what happened at CING last week (0202-0206)?
Weekly Report · 1d ago
Cingulate Advances Capital Raise with Private Placement Financing
TipRanks · 4d ago
Cingulate Inc. Raises $6.5 Million in Private Placement of Unregistered Shares
Reuters · 4d ago
Weekly Report: what happened at CING last week (0126-0130)?
Weekly Report · 02/02 10:29
CINGULATE: ENTERS SECURITIES PURCHASE AGREEMENT FOR PRIVATE PLACEMENT; INCLUDES 2.14 MLN COMMON SHARES AND 973 PREFERRED SHARES - SEC FILING
Reuters · 01/28 21:33
Cingulate Announces Private Placement and New Preferred Stock
TipRanks · 01/28 21:32
Weekly Report: what happened at CING last week (0119-0123)?
Weekly Report · 01/26 10:29
Biotech Sector Sees Broad After-Hours Gains Amid Quiet News Flow
NASDAQ · 01/23 04:42
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 01/22 12:05
Weekly Report: what happened at CING last week (0112-0116)?
Weekly Report · 01/19 10:36
Cingulate Expands At-The-Market Equity Offering Capacity
TipRanks · 01/15 21:31
Cingulate files $200M mixed securities shelf
TipRanks · 01/12 22:15
Cingulate Files For Mixed Shelf Offering Of Up To $200M
Benzinga · 01/12 22:12
CINGULATE INC : FILES FOR MIXED SHELF OFFERING OF UP TO $200 MLN- SEC FILING
Reuters · 01/12 22:10
Weekly Report: what happened at CING last week (0105-0109)?
Weekly Report · 01/12 10:35
Weekly Report: what happened at CING last week (1229-0102)?
Weekly Report · 01/05 10:28
Cingulate continues stock-for-debt exchanges to reduce liabilities
TipRanks · 01/02 22:03
Cingulate Inc. Issues Unregistered Shares to Lenders in Debt Exchange
Reuters · 01/02 21:31
Weekly Report: what happened at CING last week (1222-1226)?
Weekly Report · 12/29/2025 10:27
Weekly Report: what happened at CING last week (1215-1219)?
Weekly Report · 12/22/2025 10:27
More
Webull provides a variety of real-time CING stock news. You can receive the latest news about Cingulate Inc through multiple platforms. This information may help you make smarter investment decisions.
About CING
Cingulate Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles. It focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The Company is in the development of two lead product candidates, such as CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). The Company’s CTx-1301 and CTx-1302 are being developed for the treatment of ADHD in the three core patient segments: children (ages 6-12), adolescents (ages 13-17), and adults (ages18+). In addition, the Company has a third product to treat anxiety, CTx-2103, in a formulation stage. Its CTx-1301, CTx-1302 and CTx-2103 drug candidates contain three releases of active pharmaceutical ingredient combined into one small tablet dosage form.